全文获取类型
收费全文 | 21516篇 |
免费 | 1400篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 127篇 |
儿科学 | 446篇 |
妇产科学 | 291篇 |
基础医学 | 2836篇 |
口腔科学 | 343篇 |
临床医学 | 2637篇 |
内科学 | 3886篇 |
皮肤病学 | 200篇 |
神经病学 | 1924篇 |
特种医学 | 736篇 |
外科学 | 2966篇 |
综合类 | 238篇 |
一般理论 | 29篇 |
预防医学 | 2729篇 |
眼科学 | 436篇 |
药学 | 1705篇 |
中国医学 | 37篇 |
肿瘤学 | 1409篇 |
出版年
2024年 | 20篇 |
2023年 | 140篇 |
2022年 | 251篇 |
2021年 | 509篇 |
2020年 | 326篇 |
2019年 | 455篇 |
2018年 | 536篇 |
2017年 | 409篇 |
2016年 | 443篇 |
2015年 | 598篇 |
2014年 | 775篇 |
2013年 | 1010篇 |
2012年 | 1730篇 |
2011年 | 1756篇 |
2010年 | 995篇 |
2009年 | 944篇 |
2008年 | 1554篇 |
2007年 | 1664篇 |
2006年 | 1517篇 |
2005年 | 1493篇 |
2004年 | 1465篇 |
2003年 | 1384篇 |
2002年 | 1192篇 |
2001年 | 154篇 |
2000年 | 112篇 |
1999年 | 161篇 |
1998年 | 226篇 |
1997年 | 156篇 |
1996年 | 142篇 |
1995年 | 109篇 |
1994年 | 121篇 |
1993年 | 96篇 |
1992年 | 52篇 |
1991年 | 47篇 |
1990年 | 41篇 |
1989年 | 39篇 |
1988年 | 31篇 |
1987年 | 43篇 |
1986年 | 29篇 |
1985年 | 26篇 |
1984年 | 26篇 |
1983年 | 36篇 |
1982年 | 31篇 |
1981年 | 29篇 |
1980年 | 21篇 |
1979年 | 8篇 |
1978年 | 15篇 |
1977年 | 8篇 |
1976年 | 14篇 |
1966年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
22.
Lamiya Samad Chris Hollis Martin Prince Robert Goodman 《International journal of methods in psychiatric research》2005,14(4):230-230
The original article to which this Erratum refers was published in International Journal of Methods in Psychiatric Research, 2005; Vol.14, No.3, 158–166. Copyright © 2005 John Wiley & Sons, Ltd. 相似文献
23.
24.
25.
26.
Peter B. Arnold Chris A. Campbell George Rodeheaver Wyndell Merritt Raymond F. Morgan David B. Drake 《Hand (New York, N.Y.)》2009,4(3):302-307
The purpose of this study was to demonstrate that perivascularly applied botulinum toxin-A (BTX) increases the diameter of
treated blood vessels in a rat femoral vessel exposure model. Six adult Sprague–Dawley rats were used and bilateral femoral
artery and vein exposures were performed. Five units of BTX were applied to the experimental side and an equal volume of sterile
saline was applied to the control side. Digital images of the vessels were obtained at the following time points: pretreatment,
immediately posttreatment, and postoperative days (POD) 1, 14, and 28. Vessel diameters were equivalent at baseline and immediately
following application of BTX and saline. The BTX artery was significantly larger than the control artery on POD 1 and 14.
The BTX treated artery was significantly larger than all other vessels on POD 14 (p < 0.05) as well as all prior time points (p < 0.01). Direct perivascular application of BTX increases the diameter of rat femoral vessels as early as POD 1. The affect
is most robust on POD 14 where the artery was significantly larger than all other vessels at all time points. It is likely
that the increased diameter of blood vessels results in an increased blood flow across the area of dilation. Such an increase
in flow may serve to improve end-organ perfusion in microvascular procedures. 相似文献
27.
Antioxidant defence during cardiopulmonary bypass surgery. 总被引:1,自引:0,他引:1
Chris R Luyten Frans J van Overveld Lieve A De Backer Anna M Sadowska Inez E Rodrigus Stefan G De Hert Wilfried A De Backer 《European journal of cardio-thoracic surgery》2005,27(4):611-616
OBJECTIVE: Cardiac surgery may lead to severe oxidative stress due to formation of oxidation products generated during ischemia and reperfusion. We investigated to which extent oxidative stress influences a number of endogenous antioxidants and markers of cellular activation. METHODS: At six time points blood was withdrawn from patients undergoing coronary artery bypass grafting, using the on-pump procedure. RESULTS: Both glutathione peroxidase and superoxide dismutase show a gradual and strong increase in activity during surgery (40 and 30%, respectively), returning to baseline values 24 h after surgery. The total antioxidant capacity has a maximum increase of 60%. Markers of cellular activation, such as eosinophil cationic protein and tryptase also increase during the procedure. CONCLUSION: Cardiac surgery results in systemic inflammation accompanied or caused by severe oxidative stress. The human body has a strong innate oxidative defence screen, which is probably not sufficient to fully compensate for the total amount of oxidative damage. 相似文献
28.
Gerald S. Lipshutz Harish Mahanty Sandy Feng Ryutaro Hirose Peter G. Stock Sang-Mo Kang rew M. Posselt Chris E. Freise 《American journal of transplantation》2005,5(2):366-373
With the introduction of more potent immunosuppressive agents, rejection has decreased in simultaneous pancreas/kidney transplant (SPK) recipients. However, as a consequence, opportunistic infections have increased. The purpose of this report is to outline the course of SPK patients who developed polyomavirus-associated nephropathy (PVAN). A retrospective review of 146 consecutive SPK recipients from January 1, 1996 to December 31, 2002 was performed. Immunosuppression, rejection and development of PVAN were reviewed. Nine patients were identified. All received induction with either OKT3 or thymoglobulin. Immunosuppression included tacrolimus/cyclosporine, MMF/azathioprine and sirolimus/prednisone. Two patients were treated for kidney rejection prior to the diagnosis of PVAN. Time to diagnosis was an average of 359.3 days post-transplantation. Immunosuppression was decreased but five ultimately lost function. However, none developed pancreatic abnormalities as demonstrated by normal glucose and amylase. Two underwent renal retransplantation after PVAN diagnosis and both have normal kidney function. PVAN was the leading cause of renal loss in SPK patients in the first 2 years after transplantation and is a serious concern for SPK recipients. The pancreas, however, is spared from evidence of infection, and no pancreatic rejection occurred when immunosuppression was decreased. 相似文献
29.
The cellular complexity of the brain (some estimate that there are up to 103 different cell types) is exceeded by the synaptic complexity, with each of the ∼1011 neurons in the brain having around 103 –104 synapses. Proteomic studies of the synapse have revealed that the postsynaptic density is the most complex multiprotein structure yet identified, with ∼103 different proteins. Such studies, however, use brain tissue with many different regions and therefore different cell types, and there is clear potential for heterogeneity of protein content at different synapses within and between brain regions. Although large-scale mRNA-based assays are in progress to map this sort of complexity at the cellular level, and indeed all brain-expressed genes, analysis of protein distribution (at synapses and other structures) is still in the very early stages. We review existing large-scale protein expression studies and the specific technical obstacles that need to be overcome before applying the scaling used in nucleic acid based approaches. 相似文献
30.
Ira R Katz Marcia Rupnow Chris Kozma Lon Schneider 《The American journal of geriatric psychiatry》2004,12(5):499-508
OBJECTIVE: Authors evaluated the association between use/dosage of risperidone (RIS) and falls in a residential-care dementia population. METHODS: Authors performed secondary analysis of data from ambulatory patients in a randomized, double-blind, placebo-controlled, 12-week trial of three RIS dosages (0.5 mg/day, 1 mg/day, 2 mg/day). Outcomes included number of fallers, rate of falls, and time until the first fall after randomization. Additional analyses evaluated wandering as a potential moderating or mediating variable. RESULTS: The ambulatory sample included 537 subjects. Of those, 22.3% on placebo, 18.0% on RIS 0.5 mg/day, 12.7% on 1 mg/day, and 27.3% on 2 mg/day, respectively, fell during the trial. The difference between the RIS 1 mg/day group and placebo was significant, with a significantly lower hazard ratio in the RIS 1-mg/day group than placebo. Wandering was associated with an increased risk of falls. Among 205 patients with the highest levels of wandering at baseline, RIS 1 mg/day was associated with approximately a 70% reduction in risk for falls versus placebo condition. However, in those with the lowest levels of wandering at baseline, RIS 2 mg/day may have increased the risk of falls. CONCLUSIONS: Evaluating the benefits versus risks of risperidone in patients with dementia is complex and must consider multiple outcomes as a function of dose. At 1 mg/day, RIS was associated with decreased falls, especially in patients who exhibit wandering. However, at 2 mg/day, it may increase the risk of falls in ambulatory individuals with low levels of wandering. 相似文献